Top ▲
Target id: 2015
Nomenclature: eukaryotic translation initiation factor 2 alpha kinase 1
Abbreviated Name: HRI
Family: Other PEK family kinases
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 630 | 7p22.1 | EIF2AK1 | eukaryotic translation initiation factor 2 alpha kinase 1 | |
Mouse | - | 619 | 5 G2 | Eif2ak1 | eukaryotic translation initiation factor 2 alpha kinase 1 | |
Rat | - | 620 | 12p11 | Eif2ak1 | eukaryotic translation initiation factor 2 alpha kinase 1 |
Previous and Unofficial Names |
HCR | heme-controlled repressor | heme regulated initiation factor 2 alpha kinase | HRI |
Database Links | |
Alphafold | Q9BQI3 (Hs), Q9Z2R9 (Mm), Q63185 (Rn) |
BRENDA | 2.7.11.1 |
ChEMBL Target | CHEMBL6029 (Hs), CHEMBL1938213 (Mm) |
Ensembl Gene | ENSG00000086232 (Hs), ENSMUSG00000029613 (Mm), ENSRNOG00000001050 (Rn) |
Entrez Gene | 27102 (Hs), 15467 (Mm), 27137 (Rn) |
Human Protein Atlas | ENSG00000086232 (Hs) |
KEGG Enzyme | 2.7.11.1 |
KEGG Gene | hsa:27102 (Hs), mmu:15467 (Mm), rno:27137 (Rn) |
OMIM | 613635 (Hs) |
Pharos | Q9BQI3 (Hs) |
RefSeq Nucleotide | NM_014413 (Hs), NM_013557 (Mm), NM_013223 (Rn) |
RefSeq Protein | NP_055228 (Hs), NP_038585 (Mm), NP_037355 (Rn) |
UniProtKB | Q9BQI3 (Hs), Q9Z2R9 (Mm), Q63185 (Rn) |
Wikipedia | EIF2AK1 (Hs) |
Enzyme Reaction | ||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DiscoveRx KINOMEscan® screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1,4 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: EIF2AK1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
Immuno Process Associations | ||
|
||
|
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Li Y, Xiong Y, Zhang G, Zhang L, Yang W, Yang J, Huang L, Qiao Z, Miao Z, Lin G et al.. (2018) Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model. J Med Chem, 61 (24): 11398-11414. [PMID:30480444]
3. Rosen MD, Woods CR, Goldberg SD, Hack MD, Bounds AD, Yang Y, Wagaman PC, Phuong VK, Ameriks AP, Barrett TD et al.. (2009) Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2alpha (HRI) kinase. Bioorg Med Chem Lett, 19 (23): 6548-51. [PMID:19854648]
4. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
Other PEK family kinases: eukaryotic translation initiation factor 2 alpha kinase 1. Last modified on 11/12/2018. Accessed on 12/10/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=2015.